<DOC>
<DOCNO>EP-0632026</DOCNO> 
<TEXT>
<INVENTION-TITLE>
Alpha amino acid derivatives, a method for their preparation and pharmaceutical preparations containing them
</INVENTION-TITLE>
<CLASSIFICATIONS>C07D40112	C07F500	C07D21300	A61P306	A61K3144	A61P300	A61K314418	C07D21389	A61K314418	C07D40100	A61K3144	A61P2900	A61P2900	C07D21375	C07F502	</CLASSIFICATIONS>
<CLASSIFICATIONS-THIRD>C07D	C07F	C07D	A61P	A61K	A61P	A61K	C07D	A61K	C07D	A61K	A61P	A61P	C07D	C07F	</CLASSIFICATIONS-THIRD>
<CLASSIFICATIONS-FOURTH>C07D401	C07F5	C07D213	A61P3	A61K31	A61P3	A61K31	C07D213	A61K31	C07D401	A61K31	A61P29	A61P29	C07D213	C07F5	</CLASSIFICATIONS-FOURTH>
<ABSTRACT>
Compounds of general formula: 
<
IMAGE
>
  in which m, X, Y, A, R2 and R3 are defined in the description. Medicaments.
</ABSTRACT>
<APPLICANTS>
</APPLICANTS>
<INVENTORS>
</INVENTORS>
<CLAIMS>
Compounds of the general formula (I): 

 
wherein : 


m represents 0 or 1, 
X and Y, which are identical or different, each represents an alkyl group, 
A represents : 
1) - a grouping 

in which R
1
 represents : 

a hydrogen atom, 
an alkyl group, 
an alkyl group substituted by an amino group, 
an alkylthioalkyl group, 
an alkyl group substituted by an amino group which is itself substituted on the amino 
group by a group selected from tert-butoxycarbonyl, benzyloxycarbonyl and 

fluorenylmethoxycarbonyl, 
a phenyl or phenylalkyl group, 
a phenyl or phenylalkyl group substituted on the aromatic nucleus by an alkyl, hydroxy, 
alkoxy or trifluoromethyl group or by a halogen atom, 
 
and in that case (where A represents a -CH(R
1
)- grouping) : 
R
2
 represents a hydrogen atom or R
2
 forms together with R
1
 and the CH-N- chain member 
carrying them a mono- or bi-cyclic carbon-containing system containing the -CH-N- chain 

member, each ring having 5 or 6 ring members and it being possible for each ring to be 
saturated or unsaturated,
 
and then  

 
R
3
 represents : 

a hydrogen atom, 
a tert-butoxycarbonyl, benzyloxycarbony or fluorenylmethoxycarbonyl group, 
a benzoyl group, 
a benzoyl group substituted by an alkyl, alkoxy, hydroxy or trifluoromethyl group or by a 
halogen atom, 
a grouping 

 
wherein R
A
, R
B
 and R
C
,
 
which are identical are different, each represents a hydrogen atom or an alkyl group, or two 

of the groups R
A
, R
B
 and R
C
 form together with the nitrogen atom carrying them a 
heterocyclic system selected from pyrrolidine, piperidine, azepine and morpholine, the third 

of the groups R
A
, R
B
 and R
C
 then being either a hydrogen atom or an alkyl group, 
a grouping 
wherein R
8
 represents hydrogen, tert-butoxycarbonyl, benzyloxycarbonyl, fluorenylmethoxycarbonyl, 
glycyl or glycyl substituted by a tert-butoxycarbonyl, benzyloxycarbonyl or 

fluorenylmethoxycarbonyl group and R
10
 represents hydrogen; alkyl; alkyl substituted by an 
amino group; alkyl substituted by an amino group which is itself substituted by a tert-butoxycarbonyl, 

benzyloxycarbonyl or fluorenylmethoxycarbonyl group; a phenyl or 
phenylalkyl group, or a phenyl or phenylalkyl group substituted on the phenyl nucleus by an 

alkyl, hydroxy, alkoxy or trifluoromethyl group or by a halogen atom, 
2) - a grouping 

 
the 


 
group of the radical A being 

bonded to the 

 
grouping of the compound of formula (I) and n being an 

integer of from 1 to 6 inclusive,
 
and in that case R
3
 represents a grouping 

R
1
 and R
2
 being as defined above and R
5
 representing a B(OH)
2
, carboxy, alkoxycarbonyl or  
 


 
grouping in which 
R
6
 and R
1
, which are identical or different, each has the definition given above for R
1
, and R
7
 
has the definition given above for R
2
 and is identical to or different from R
2
,
 
their isomers, epimers, enantiomers and diastereoisomers, and also the addition salts thereof 

with a pharmaceutically acceptable acid or base,
 
there being understood by "alkyl" and "alkoxy" linear or branched groups having from 1 to 6 

carbon atoms. 
Compounds according to claim 1 of the general formula (I): 

 
wherein : 


m represents 0 or 1, 
X and Y, which are identical or different, each represents an alkyl group, 
and 
A represents a grouping 

in which R
1
 represents 

a hydrogen atom, 
an alkyl group, 
an alkyl group substituted by an amino group, 
an alkylthioalkyl group, 
an alkyl group substituted by an amino group which is itself substituted on the amino group 
by a group selected from tert-butoxycarbonyl, benzyloxycarbonyl and 

fluorenylmethoxycarbonyl, 
a phenyl or phenylalkyl group, 
a phenyl or phenylalkyl group substituted on the aromatic nucleus by an alkyl, hydroxy, 
alkoxy or trifluoromethyl group or by a halogen atom, 
R
2
 represents a hydrogen atom or R
2
 forms together with R
1
 and the CH-N- chain member 
carrying them a mono- or bi-cyclic carbon-containing system containing the -CH-N- chain 

member, each ring having 5 or 6 ring members and it being possible for each ring to be 
saturated or unsaturated,
 
and 
R
3
 represents : 

a hydrogen atom, 
a tert-butoxycarbonyl, benzyloxycarbonyl or fluorenylmethoxycarbonyl group, 
a benzoyl group, 
a benzoyl group substituted by an alkyl, alkoxy, hydroxy or trifluoromethyl group or by a 
halogen atom, 
a grouping 

 
wherein R
A
, R
B
 and R
C
, 
 
which are identical are different, each represents a hydrogen atom or an alkyl group, or two of 

the groups R
A
, R
B
 and R
C
 form together with the nitrogen atom carrying them a heterocyclic 
system selected from pyrrolidine, piperidine, azepine and morpholine, the third of the groups 

R
A
, R
B
 and R
C
 then being either a hydrogen atom or an alkyl group,
 
their isomers, epimers, enantiomers and diastereoisomers, and also the addition salts thereof 

with a pharmaceutically acceptable acid or base,
 
there being understood by "alkyl" and "alkoxy" linear or branched groups having from 1 to 6 

carbon atoms. 
Compounds of the general formula (I) according to claim 1 : 

 
wherein : 


m represents 0 or 1,  

 
X and Y, which are identical or different, each represents an alkyl group, 
A represents a grouping 

 
the 


 
group of the radical A being 

bonded to the grouping 

 
of the compound of formula (I) and n being an 

integer of from 1 to 6 inclusive, 
R
3
 represents a grouping 

in which R
1
 represents : 

a hydrogen atom, 
an alkyl group, 
an alkyl group substituted by an amino group, 
an alkylthioalkyl group, 
an alkyl group substituted by an amino group which is itself substituted on the amino 
group by a group selected from tert-butoxycarbonyl, benzyloxycarbonyl and fluorenylmethoxycarbonyl, 
a phenyl or phenylalkyl group, 
a phenyl or phenylalkyl group substituted on the aromatic nucleus by an alkyl, hydroxy, 
alkoxy or trifluoromethyl group or by a halogen atom, 
and R
2
 represents a hydrogen atom or R
2
 forms together with R
1
 and the CH-NR
3
- chain 
member carrying them a mono- or bi-cyclic carbon-containing system containing the 

-CH-N(R
3
)- chain member, each ring having 5 or 6 ring members and it being possible for 
each ring to be saturated or unsaturated, 
R
5
 representing a B(OH)
2
, carboxy, alkoxycarbonyl 

 
or 

grouping in which R
6
 and R
1
, which are identical or different, each has the definition given 
above for R
1
, and R
7
 has the definition given above for R
2
 and is identical to or different 
from R
2
,
 
their isomers, epimers, enantiomers and diastereoisomers, and the addition salts thereof with 

a pharmaceutically acceptable acid or base. 
Compounds of the general formula (I/A) according to claim 1 : 

wherein m is 0 or 1, X and Y, which are identical or different, each represents an alkyl group 
and A represents a grouping 

in which R
1
 represents : 

a hydrogen atom, 
an alkyl group substituted by an amino group, 
an alkylthioalkyl group, 
an alkyl group substituted by an amino group which is itself substituted on the amino 
group by a group selected from tert-butoxycarbonyl, benzyloxycarbonyl and fluorenylmethoxycarbonyl, 
a phenyl or phenylalkyl group, 
a phenyl or phenylalkyl group substituted on the aromatic nucleus by an alkyl, hydroxy, 
alkoxy or trifluoromethyl group or by a halogen atom, 
and R
3
 represents : 

a grouping 

in which R
8
 represents hydrogen, tert-butoxycarbonyl, benzyloxycarbonyl or fluorenylmethoxycarbonyl 
and R
10
 represents hydrogen; alkyl; alkyl substituted by an amino group; 
alkyl substituted by an amino group which is itself substituted by a tert-butoxycarbonyl, 

benzyloxycarbonyl or fluorenylmethoxycarbonyl group; a phenyl or phenylalkyl group, or a 
phenyl or phenylalkyl group substituted on the phenyl nucleus by an alkyl, hydroxy, alkoxy 

or trifluoromethyl group or by a halogen atom,
 
their isomers, epimers, enantiomers and diastereoisomers, and the addition salts thereof with 

a pharmaceutically acceptable acid or base. 
Compounds of formula (I/A) according to claim 1 : 

wherein m represents 0 or 1, A represents a grouping 

 
in which R
1
 is selected 
from hydrogen, alkyl and benzyl, R
2
 represents hydrogen, benzyloxycarbonyl or tert-butoxycarbonyl, 
and R
3
 represents : 

in which R
8
 represents hydrogen, tert-butoxycarbonyl, benzyloxycarbonyl, fluorenylmethoxycarbonyl, 
glycyl or glycyl substituted by a tert-butoxycarbonyl, benzyloxycarbonyl 

or fluorenylmethoxycarbonyl group and R
10
 represents hydrogen; alkyl; alkyl substituted by 
an amino group; alkyl substituted by an amino group which is itself substituted by a tert-butoxycarbonyl, 

benzyloxycarbonyl or fluorenylmethoxycarbonyl group; a phenyl or 
phenylalkyl group, or a phenyl or phenylalkyl group substituted on the phenyl nucleus by an 

alkyl, hydroxy, alkoxy or trifluoromethyl group or by a halogen atom,
 
their isomers, epimers, enantiomers and diastereoisomers, and the addition salts thereof with 

a pharmaceutically acceptable acid or base. 
Compounds of formula (I/A) according to claim 1 : 

wherein m represents 0 or 1, A represents a grouping 

 
in which R
1
 is 
selected from hydrogen, alkyl and benzyl, R
2
 represents hydrogen and R
3
 represents a 
grouping 


in which R
8
 represents hydrogen, tert-butoxycarbonyl, benzyloxycarbonyl, fluorenylmethoxycarbonyl, 
glycyl or glycyl substituted by a tert-butoxycarbonyl, benzyloxycarbonyl 

or fluorenylmethoxycarbonyl group and R
10
 represents hydrogen; alkyl; alkyl substituted by 
an amino group; alkyl substituted by an amino group which is itself substituted by a tert-butoxycarbonyl, 

benzyloxycarbonyl or fluorenylmethoxycarbonyl group; a phenyl or 
phenylalkyl group, or a phenyl or phenylalkyl group substituted on the phenyl nucleus by an 

alkyl, hydroxy, alkoxy or trifluoromethyl group or by a halogen atom,
 
their isomers, epimers, enantiomers and diastereoisomers, and the addition salts thereof with 

a pharmaceutically acceptable acid or base. 
Compound according to claim 1, which is N-2-benzyloxycarbonyl-N-(4,6-dimethylpyridin-2-yl)prolinamide, 
its N-oxide, the isomers thereof, and also the addition salts thereof 

with a pharmaceutically acceptable acid or base. 
Compound according to claim 1, which is N-2-benzyloxycarbonyl-N-(4,6-dimethylpyridin-2-yl)glycinamide, 
its N-oxide, and also the addition salts thereof with a 

pharmaceutically acceptable acid or base. 
Compound according to claim 1, which is N-2-(3-fluorobenzoyl)-N-(4,6-dimethylpyridin-2-yl)glycinamide, 
its N-oxide, and also the addition salts thereof with a pharmaceutically 

acceptable acid or base. 
Compounds of formula I according to claim 1 wherein A represents a grouping : 

 
and R
3
 represents a grouping 

 
wherein  

 
R
A
, R
B
 and R
C
, which are identical are different, each represents a hydrogen atom or an alkyl 
group, or two of the groups R
A
, R
B
 and R
C
 form together with the nitrogen atom carrying 
them a heterocyclic system selected from pyrrolidine, piperidine, azepine and morpholine, 

the third of the groups R
A
, R
B
 and R
C
 then being either a hydrogen atom or an alkyl group 
and being identical or different, their isomers and also their N-oxides, and the addition salts 

thereof with a pharmaceutically acceptable acid or base. 
Compound according to claim 1, which is ethyl N-{[1,4-dioxo-4-(4,6-dimethylpyridin-2-ylamino)]butyl}glycinate, 

and also its N-oxide, and the addition salts thereof with a 
pharmaceutically acceptable acid or base. 
Compound according to claim 1, which is {[N-(4,6-dimethylpyridin-2-yl)-2-leucinamido]carbonyl}trimethylaminoboron 

dihydride, and also its N-oxide, and the addition 
salts thereof with a pharmaceutically acceptable acid or base. 
Compound according to claim 1, which is {[N-(4,6-dimethylpyridin-2-yl)-2-methioninamido]carbonyl}trimethylaminoboron 

dihydride, its N-oxide, its isomers, and also 
the addition salts thereof with a pharmaceutically acceptable acid or base. 
Compound according to claim 1, which is N-(4,6-dimethylpyridin-2-yl)glycinamide, and 
also its N-oxide, and the addition salts thereof with a pharmaceutically acceptable acid or 

base. 
Compound according to claim 1, which is N-(4,6-dimethylpyridin-2-yl)glycyl 
glycinamide, and also its N-oxide, and the addition salts thereof with a pharmaceutically 

acceptable acid or base. 
Compound according to claim 1, which is N-(4,6-dimethylpyridin-2-yl)glycylgylcyl 
glycinamide, and also its N-oxide, and the addition salts thereof with a pharmaceutically 

acceptable acid or base. 
Process for the synthesis of compounds of formula (I) according to claim 1, wherein : 

A represents a grouping 

 
characterised in that the starting material used is a compound of formula (II) :  

 

wherein X and Y, which are identical or different, each represents an alkyl group, 
which compound is condensed with a compound of formula (III) : 


wherein R
1
 and R
2
 are as defined for formula (I), 
and R
30
 represents a tert-butoxycarbonyl, benzyloxycarbonyl or fluorenylmethoxycarbonyl 
group or a grouping 


in which R
10
 is as defined above and R
18
 represents a tert-butoxycarbonyl, benzyloxycarbonyl 
or fluorenylmethoxycarbonyl group,
 
to yield a compound of formula (IV) : 


 
a particular case of compounds of formula (I) in which A represents a grouping 


 
and R
3
 represents a grouping R
30
 as defined above,
 
which compound of formula (IV) may then be deprotected to yield a compound of 

formula (V) : 

wherein R
1
, R
2
, X and Y are as defined above and R
30'
 represents either a hydrogen atom or a 
grouping 


in which R
10
 is as defined above,
 
a particular case of compounds of formula (I) wherein R
3
 represents a group R
30'
 and A 
represents a grouping 


 
R
1
 and R
30'
 being as defined above,
 
which compound of formula (V), when R
30'
 represents a hydrogen atom, may be condensed 
with a compound of formula (VI) 


R
9
COOH
in which R
9
 represents : 

a phenyl group, 
a phenyl group substituted by an alkyl, alkoxy, hydroxy or trifluoromethyl group or by a 
halogen atom, 
a grouping 

 
in which R
A
, R
B
 and R
C
 are as defined above, 
a grouping 

in which R
18
 represents tert-butoxycarbonyl, benzyloxycarbonyl, fluorenylmethoxycarbonyl, 
glycyl or glycyl substituted by a tert-butoxycarbonyl, benzyloxycarbonyl or fluorenylmethoxycarbonyl 

group and R
10
 is as defined above, to yield a compound of formula (VII) : 

wherein R, R
2
, R
9
. X and Y are as defined above, a particular case of compounds of 
formula (I) wherein A represents a grouping 


 
and R
3
 represents a grouping 
-CO-R
9
 in which R
1
 and R
9
 are as defined above,
 
which compound, when R
9
 represents a grouping 

 
may, if desired, be subjected to deprotection to yield a compound of formula (XVII) 


wherein R
18'
 represents a hydrogen atom or a glycyl radical and R
1
, R
2
, R
10
, X and Y are as 
defined above,
 
a particular case of compounds of formula (I) wherein A represents a grouping 


 
and R
3
 represents a grouping 

 
in which R
1
, R
18'
 and R
10
 are as defined above,
 
which compounds of formula (IV), (V), (VII) and (XVII) are converted into N-oxides by 

treatment with hydrogen peroxide and/or, where appropriate, are separated into their isomers 
and, if desired, are converted into salts with a pharmaceutically acceptable acid or base. 
Process for the synthesis of compounds of formula (I) according to claim 1, wherein A 
represents a grouping (CH
2
)
n
CO in which n is from 1 to 6 inclusive, characterised in that the 
starting material used is a compound of formula (II) : 


wherein X and Y, which are identical or different, each represents an alkyl group, 
which compound is condensed
 
with a compound of formula (VIII) :  

 

wherein n is as defined above, Hal represents a halogen atom and E represents an alkoxy 
group, to obtain a compound of formula (IX) : 


wherein n, X, Y and E are as defined above,
 
which, when treated with an alkaline agent, yields a compound of formula (X) : 


wherein n, X and Y are as defined above,
 
which is treated : 


either with a compound of formula (XI) : 

wherein R
1
 and R
2
 are as defined above and Alk represents an alkyl group,
 
to yield a compound of formula (XII) : 


 
a particular case of a compound of formula (I) wherein A represents a grouping (CH
2
)
n
CO  
 

and R
3
 represents a grouping 

 
in which R
5
 represents alkoxycarbonyl, and n, R
1
 
and R
2
 are as defined above,
 
which compound of formula (XII), on deprotection, yields a compound of formula (XIII) : 


 
a particular case of compounds of formula (I) wherein A represents a grouping (CH
2
)
n
CO 
and R
3
 represents a grouping 

 
in which R
5
 in this case represents a carboxyl group, 
and n, R
1
 and R
2
 are as defined above,
 
which compound of formula (XIII) may be treated with a compound of formula (XIV) : 


 
wherein R
6
 and R
7
 are as defined for formula (I),
 
which has been protected where necessary, to yield, after deprotection where required, a 

compound of formula (XV) : 

 
a particular case of compounds of formula (I) wherein A represents a grouping -(CH
2
)
n
CO- and 
R
3
 represents a grouping 

 
in which R
5
 represents a grouping 

n, R
5
, R
1
, R
6
 and R
7
 being as defined for formula (I), 

or directly with a compound of formula (XIV), which has been protected where necessary, 
to yield, after deprotection where required, a compound of formula (XVI) : 


 
a particular case of a compound of formula (I) wherein A represents a grouping 


 
and R
3
 represents a grouping 

 
in which R
5
 in this case represents a B(OH)
2
 
group, and wherein R
6
 has the definition given above for R
1
, and R
7
 has the definition given 
above for R
2
,
 
which compounds of formula (XII), (XIII), (XV) and (XVI) are converted into the N-oxides 

by treatment with hydrogen peroxide and/or, where applicable, separated into their isomers 
and, if desired, converted into salts with a pharmaceutically acceptable acid or base. 
Pharmaceutical composition comprising as active ingredient at least one compound 
according to any one of claims 1 to 16 in combination with one or more pharmaceutically 

acceptable, inert, non-toxic excipients or carriers. 
Pharmaceutical composition according to claim 19, comprising at least one active 
ingredient according to any one of claims 1 to 16 utilisable in the treatment of inflammatory 

disorders, of psoriasis in hypercholesterolaemia and hypertriglyceridaemia, and also in 
psoriasis. 
</CLAIMS>
</TEXT>
</DOC>
